Leuven, Belgium

Johan Robben

This inventor holds 1 USPTO granted patent. Top assignee: K.u. Leuven Research & Development. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Johan Robben in Biocatalysis

Introduction

Johan Robben is a notable inventor based in Leuven, Belgium. He has made significant contributions to the field of biocatalysis, particularly through his innovative methods for enzyme inhibitors. His work has implications for various industrial applications, showcasing the importance of research and development in this area.

Latest Patents

Johan Robben holds a patent for "Biocatalyst inhibitors." This invention concerns a method for the separation and/or isolation of inhibitors of cellulolytic, xylanolytic, and/or beta-glucanolytic enzymes. The patent outlines inhibitors obtainable by this method, as well as processes for obtaining microorganisms, plants, or plant materials wherein the activity of the inhibitor is increased or reduced. Additionally, it discusses the use of these inhibitors in conjunction with selected or modified endoxylanases across various processes and applications. He has 1 patent to his name.

Career Highlights

Johan Robben is affiliated with K.U. Leuven Research & Development, where he has been instrumental in advancing research in biocatalysis. His work has not only contributed to academic knowledge but has also paved the way for practical applications in industry.

Collaborations

Some of his notable coworkers include Jan Delcour and Kurt Gebruers. Their collaborative efforts have further enhanced the research output and innovation at K.U. Leuven.

Conclusion

Johan Robben's contributions to the field of biocatalysis through his innovative patent demonstrate the vital role of inventors in advancing scientific knowledge and practical applications. His work continues to influence the industry and inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…